11.13.14
WuXi PharmaTech
3Q Revenues: $173.6 million (+18%)
3Q Earnings: $32.0 million (+5%)
YTD Revenues: $483.6 million (+15%)
YTD Earnings: $79.2 million (-3%)
Comments: Lab services revenue grew 17% in the quarter to $126.0 million, with China-based revenue up 18% to $100.5 million and U.S.-based revenue up 11% to $25.5 million. Manufacturing revenues were $47.6 million, up 23%.
3Q Revenues: $173.6 million (+18%)
3Q Earnings: $32.0 million (+5%)
YTD Revenues: $483.6 million (+15%)
YTD Earnings: $79.2 million (-3%)
Comments: Lab services revenue grew 17% in the quarter to $126.0 million, with China-based revenue up 18% to $100.5 million and U.S.-based revenue up 11% to $25.5 million. Manufacturing revenues were $47.6 million, up 23%.
